Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Diprenorphine Hydrochloride
2. Hydrochloride, Diprenorphine
3. Revivon
1. 14357-78-9
2. Diprenorfin
3. Revivon
4. Dea No. 9058
5. 1f0l5n25zz
6. Chebi:4650
7. Chembl281786
8. M. 5050
9. Diprenorphine (inn)
10. M50-50 Injection
11. M5050
12. Diprenorphine [inn:ban]
13. Diprenorphine [inn]
14. M-5050
15. Diprenorfina [inn-spanish]
16. (1s,2s,6r,14r,15r,16r)-5-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
17. Diprenorfina
18. Diprenorphinum
19. 21-cyclopropyl-6,7,8,14-tetrahydro-7alpha-(1-hydroxy-1-methylethyl)-6,14-endo-ethanooripavine
20. Diprenorphinum [inn-latin]
21. Unii-1f0l5n25zz
22. (5?,7?)-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-?,?-dimethyl-6,14-ethenomorphinan-7-methanol
23. Einecs 238-325-7
24. M 5050 Injection
25. Diprenorphine-hcl
26. Diprenorphine [mi]
27. M50-50
28. Schembl164910
29. Gtpl1617
30. Dtxsid00903941
31. Zinc4102215
32. Bdbm50001714
33. Akos024457358
34. Db01548
35. 6,14-ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-.alpha.,.alpha.-dimethyl-, (5.alpha.,7.alpha.)-
36. 6,14-ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)-
37. Hy-107742
38. D07863
39. M 5050
40. Q424009
41. Epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)-
42. (5alpha,7alpha)-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-6,14-ethenomorphinan-7-methanol
43. 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-?,?-dimethyl-6,14-ethenomorphinan-7-methanol
44. 2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(1s,2r,6s,14r,15r,16r)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-2-propanol
45. 2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(1s,2r,6s,14r,15r,16r)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-2-propanol(diprenorphine)
46. 2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7(12),8,10-trien-16-yl]-2-propanol
47. 6,14-endo-ethanotetrahydrooripavine, 21-cyclopropyl-7a-(1-hydroxy-1-methylethyl)- (8ci) 1-n-cyclopropylmethyl-6,7,8,14-tetrahydro-6,14-endoethano-7-(2'-hydroxy-2'-propyl)nororipavine
48. 6,14-ethenomorphinan-3-ol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-18-(1-hydroxy-1-methylethyl)-6-methoxy-, (5alpha,6beta,14beta,18r)-
49. 6,14-ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)- (9ci)
Molecular Weight | 425.6 g/mol |
---|---|
Molecular Formula | C26H35NO4 |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 425.25660860 g/mol |
Monoisotopic Mass | 425.25660860 g/mol |
Topological Polar Surface Area | 62.2 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 783 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Diprenorphine is indicated to reverse the effects of powerful opioids including etorphine and carfentanil, often used for tranquilizing large animals. This drug is not approved for use in humans.
Narcotic Antagonists
Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)
Diprenorphine binds approximately equally to the three subtypes of opioid receptorsand antagonizes them.
ABOUT THIS PAGE
A Diprenorphine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diprenorphine, including repackagers and relabelers. The FDA regulates Diprenorphine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diprenorphine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Diprenorphine supplier is an individual or a company that provides Diprenorphine active pharmaceutical ingredient (API) or Diprenorphine finished formulations upon request. The Diprenorphine suppliers may include Diprenorphine API manufacturers, exporters, distributors and traders.
Diprenorphine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diprenorphine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diprenorphine GMP manufacturer or Diprenorphine GMP API supplier for your needs.
A Diprenorphine CoA (Certificate of Analysis) is a formal document that attests to Diprenorphine's compliance with Diprenorphine specifications and serves as a tool for batch-level quality control.
Diprenorphine CoA mostly includes findings from lab analyses of a specific batch. For each Diprenorphine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diprenorphine may be tested according to a variety of international standards, such as European Pharmacopoeia (Diprenorphine EP), Diprenorphine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diprenorphine USP).
LOOKING FOR A SUPPLIER?